Tesamorelin & CJC-1295 (Mod GRF 1-29) & Ipamorelin Blend (12mg) is a combination of peptides that may potentially interact with receptors in the pituitary gland. This blend may activate pituitary cells responsible for growth hormone (hGH) production.
Tesamorelin is a synthetic peptide that appears to act as an analog for growth hormone-releasing hormone (GHRH).[1] It may potentially interact with specific receptors in the pituitary and the hypothalamus, known as GHRH receptors. The activation of these receptors appears to trigger a release of growth hormone from pituitary cells.
Mod GRF (Modified Growth Hormone-Releasing Factor), also known as CJC-1295 without DAC (Drug Affinity Complex), is a synthetic peptide analog of the endogenous growth hormone-releasing hormone (GHRH).[2] It is a tetrasubstituted version of the shortest GHRH sequence. The peptide may potentially trigger GHRH receptors – GRF (1-29). It appears to bind to GHRH receptors in the pituitary cells associated with the release of hGH.

